Literature DB >> 24798212

Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme.

Miqdad Asaria1, Susan Griffin, Richard Cookson, Sophie Whyte, Paul Tappenden.   

Abstract

This paper presents an application of a new methodological framework for undertaking distributional cost-effectiveness analysis to combine the objectives of maximising health and minimising unfair variation in health when evaluating population health interventions. The National Health Service bowel cancer screening programme introduced in 2006 is expected to improve population health on average and to worsen population health inequalities associated with deprivation and ethnicity--a classic case of 'intervention-generated inequality'. We demonstrate the distributional cost-effectiveness analysis framework by examining two redesign options for the bowel cancer screening programme: (i) the introduction of an enhanced targeted reminder aimed at increasing screening uptake in deprived and ethnically diverse neighbourhoods and (ii) the introduction of a basic universal reminder aimed at increasing screening uptake across the whole population. Our analysis indicates that the universal reminder is the strategy that maximises population health, while the targeted reminder is the screening strategy that minimises unfair variation in health. The framework is used to demonstrate how these two objectives can be traded off against each other, and how alternative social value judgements influence the assessment of which strategy is best, including judgements about which dimensions of health variation are considered unfair and judgements about societal levels of inequality aversion.
© 2014 The Authors. Health Economics published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cost-effectiveness analysis; equity; health inequality

Mesh:

Year:  2014        PMID: 24798212     DOI: 10.1002/hec.3058

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  29 in total

1.  Health technology assessment with risk aversion in health.

Authors:  Darius N Lakdawalla; Charles E Phelps
Journal:  J Health Econ       Date:  2020-06-06       Impact factor: 3.883

2.  HTA - Algorithm or Process? Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".

Authors:  Anthony J Culyer
Journal:  Int J Health Policy Manag       Date:  2016-08-01

Review 3.  Integrating social justice concerns into economic evaluation for healthcare and public health: A systematic review.

Authors:  Vadim Dukhanin; Alexandra Searle; Alice Zwerling; David W Dowdy; Holly A Taylor; Maria W Merritt
Journal:  Soc Sci Med       Date:  2017-12-14       Impact factor: 4.634

4.  After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator?

Authors:  Mark Sculpher; Stephen Palmer
Journal:  Pharmacoeconomics       Date:  2020-03       Impact factor: 4.981

5.  Modelling tool to support decision-making in the NHS Health Check programme: workshops, systematic review and co-production with users.

Authors:  Martin O'Flaherty; Ffion Lloyd-Williams; Simon Capewell; Angela Boland; Michelle Maden; Brendan Collins; Piotr Bandosz; Lirije Hyseni; Chris Kypridemos
Journal:  Health Technol Assess       Date:  2021-05       Impact factor: 4.014

6.  Incorporating health equity into value assessment: frameworks, promising alternatives, and future directions.

Authors:  Vakaramoko Diaby; Askal Ali; Aram Babcock; Joseph Fuhr; Dejana Braithwaite
Journal:  J Manag Care Spec Pharm       Date:  2021-09

7.  Distributional Cost-Effectiveness Analysis: A Tutorial.

Authors:  Miqdad Asaria; Susan Griffin; Richard Cookson
Journal:  Med Decis Making       Date:  2015-04-23       Impact factor: 2.583

8.  Cost Effectiveness of Colorectal Cancer Screening Interventions with Their Effects on Health Disparity Being Considered.

Authors:  Kwang-Sig Lee; Eun-Cheol Park
Journal:  Cancer Res Treat       Date:  2015-12-28       Impact factor: 4.679

9.  Valuing Protection against Health-Related Financial Risks.

Authors:  Jonathan Skinner; Kalipso Chalkidou; Dean T Jamison
Journal:  J Benefit Cost Anal       Date:  2019-02-08

10.  Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial.

Authors:  Stéphane Verguet; Jane J Kim; Dean T Jamison
Journal:  Pharmacoeconomics       Date:  2016-09       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.